- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Market Overview
The global Active Transdermal Drug Delivery Device market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Active Transdermal Drug Delivery Device market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Active Transdermal Drug Delivery Device market is split by Type and Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Breakdown by Type, Active Transdermal Drug Delivery Device market has been segmented into Patches, Gels, etc.
Breakdown by Application, Active Transdermal Drug Delivery Device has been segmented into Clinic, Hospital, Home Use, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Active Transdermal Drug Delivery Device market presented in the report. This section sheds light on the sales growth of different regional and country-level Active Transdermal Drug Delivery Device markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Active Transdermal Drug Delivery Device market.
For Japan, this report analyses the Japan market by players, Type and Application, for the period 2015-2025.
Competitive Landscape and Active Transdermal Drug Delivery Device Market Share Analysis
Active Transdermal Drug Delivery Device competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Active Transdermal Drug Delivery Device sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Active Transdermal Drug Delivery Device sales, revenue and market share for each player covered in this report.
The major players covered in Active Transdermal Drug Delivery Device are: Novartis AG, Bayer AG, Johnson & Johnson (Janssen Pharmaceuticals Inc.), Noven Pharmaceuticals, Inc., Actavis, Inc., Transdermal Corp., Corium International, Inc., 3M, Mylan N.V., Boehringer Ingelheim GmbH, Echo Therapeutics, Inc., GlaxoSmithKline plc, etc. Among other players domestic and global, Active Transdermal Drug Delivery Device market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The key market players for global Active Transdermal Drug Delivery Device market are listed below:
Novartis AG
Bayer AG
Johnson & Johnson (Janssen Pharmaceuticals Inc.)
Noven Pharmaceuticals, Inc.
Actavis, Inc.
Transdermal Corp.
Corium International, Inc.
3M
Mylan N.V.
Boehringer Ingelheim GmbH
Echo Therapeutics, Inc.
GlaxoSmithKline plc
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa)
Market segment by Type, covers:
Patches
Gels
Market segment by Application, can be divided into
Clinic
Hospital
Home Use
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Active Transdermal Drug Delivery Device Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Active Transdermal Drug Delivery Device Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Patches
1.2.3 Gels
1.3 Market Analysis by Application
1.3.1 Overview: Global Active Transdermal Drug Delivery Device Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Home Use
1.4 Global Active Transdermal Drug Delivery Device Market Size and Forecast (2015-2025)
1.4.1 Global Active Transdermal Drug Delivery Device Revenue and Forecast (2015-2025)
1.4.2 Global Active Transdermal Drug Delivery Device Sales and Forecast (2015-2025)
1.5 Global Active Transdermal Drug Delivery Device Market Size Overview by Geography (2015-2020)
2 Manufacturers Profiles
2.1 Novartis AG
2.1.1 Novartis AG Details
2.1.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis AG SWOT Analysis
2.1.4 Novartis AG Product and Services
2.1.5 Novartis AG Active Transdermal Drug Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bayer AG
2.2.1 Bayer AG Details
2.2.2 Bayer AG Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bayer AG SWOT Analysis
2.2.4 Bayer AG Product and Services
2.2.5 Bayer AG Active Transdermal Drug Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
2.3.1 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Details
2.3.2 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) SWOT Analysis
2.3.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Product and Services
2.3.5 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Noven Pharmaceuticals, Inc.
2.4.1 Noven Pharmaceuticals, Inc. Details
2.4.2 Noven Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Noven Pharmaceuticals, Inc. SWOT Analysis
2.4.4 Noven Pharmaceuticals, Inc. Product and Services
2.4.5 Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Actavis, Inc.
2.5.1 Actavis, Inc. Details
2.5.2 Actavis, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Actavis, Inc. SWOT Analysis
2.5.4 Actavis, Inc. Product and Services
2.5.5 Actavis, Inc. Active Transdermal Drug Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Transdermal Corp.
2.6.1 Transdermal Corp. Details
2.6.2 Transdermal Corp. Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Transdermal Corp. SWOT Analysis
2.6.4 Transdermal Corp. Product and Services
2.6.5 Transdermal Corp. Active Transdermal Drug Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Corium International, Inc.
2.7.1 Corium International, Inc. Details
2.7.2 Corium International, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Corium International, Inc. SWOT Analysis
2.7.4 Corium International, Inc. Product and Services
2.7.5 Corium International, Inc. Active Transdermal Drug Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 3M
2.8.1 3M Details
2.8.2 3M Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 3M SWOT Analysis
2.8.4 3M Product and Services
2.8.5 3M Active Transdermal Drug Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Mylan N.V.
2.9.1 Mylan N.V. Details
2.9.2 Mylan N.V. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Mylan N.V. SWOT Analysis
2.9.4 Mylan N.V. Product and Services
2.9.5 Mylan N.V. Active Transdermal Drug Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Boehringer Ingelheim GmbH
2.10.1 Boehringer Ingelheim GmbH Details
2.10.2 Boehringer Ingelheim GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Boehringer Ingelheim GmbH SWOT Analysis
2.10.4 Boehringer Ingelheim GmbH Product and Services
2.10.5 Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Echo Therapeutics, Inc.
2.11.1 Echo Therapeutics, Inc. Details
2.11.2 Echo Therapeutics, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Echo Therapeutics, Inc. SWOT Analysis
2.11.4 Echo Therapeutics, Inc. Product and Services
2.11.5 Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 GlaxoSmithKline plc
2.12.1 GlaxoSmithKline plc Details
2.12.2 GlaxoSmithKline plc Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 GlaxoSmithKline plc SWOT Analysis
2.12.4 GlaxoSmithKline plc Product and Services
2.12.5 GlaxoSmithKline plc Active Transdermal Drug Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Global Active Transdermal Drug Delivery Device Market, Company Landscape
3.1 Company Market Share Analysis: Global
3.1.1 Global Active Transdermal Drug Delivery Device Sales and Market Share by Manufacturer (2018-2019)
3.1.2 Global Active Transdermal Drug Delivery Device Revenue and Market Share by Manufacturer (2018-2019)
3.2 Company Market Share Analysis: Japan
3.2.1 Key Players Active Transdermal Drug Delivery Device Sales in Japan (2018-2019)
3.2.2 Japan Active Transdermal Drug Delivery Device Revenue Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Active Transdermal Drug Delivery Device Manufacturer Market Share in 2019
3.3.2 Top 6 Active Transdermal Drug Delivery Device Manufacturer Market Share in 2019
4 Market Size by Geography
4.1 Global Active Transdermal Drug Delivery Device Market Size by Geography (2015-2020)
4.1.1 Global Active Transdermal Drug Delivery Device Sales by Geography (2015-2020)
4.1.2 Global Active Transdermal Drug Delivery Device Revenue by Regions (2015-2020)
4.2 Global Active Transdermal Drug Delivery Device Market Size and Forecast by Regions (2020-2025)
4.2.1 Global Active Transdermal Drug Delivery Device Sales and Forecast by Regions (2020-2025)
4.2.2 Global Active Transdermal Drug Delivery Device Revenue and Forecast by Regions (2020-2025)
4.3 North America Active Transdermal Drug Delivery Device Market Size and Forecast (2015-2025)
4.4 Europe Active Transdermal Drug Delivery Device Market Size and Forecast (2015-2025)
4.5 Asia-Pacific Active Transdermal Drug Delivery Device Market Size and Forecast (2015-2025)
4.6 South America Active Transdermal Drug Delivery Device Market Size and Forecast (2015-2025)
4.7 Middle East and Africa Active Transdermal Drug Delivery Device Market Size and Forecast (2015-2025)
5 North America by Country
5.1 North America Active Transdermal Drug Delivery Device Market Size by Country (2015-2020)
5.1.1 North America Active Transdermal Drug Delivery Device Sales and Market Share by Country (2015-2020)
5.1.2 North America Active Transdermal Drug Delivery Device Revenue and Market Share by Country (2015-2020)
5.2 North America Active Transdermal Drug Delivery Device Market Size and Forecast by Country (2020-2025)
5.2.1 North America Active Transdermal Drug Delivery Device Sales and Forecast by Country (2020-2025)
5.2.2 North America Active Transdermal Drug Delivery Device Revenue and Forecast by Country (2020-2025)
5.3 United States Active Transdermal Drug Delivery Device Market Size and Forecast (2015-2025)
5.4 Canada Active Transdermal Drug Delivery Device Market Size and Forecast (2015-2025)
5.5 Mexico Active Transdermal Drug Delivery Device Market Size and Forecast (2015-2025)
6 Europe by Country
6.1 Europe Active Transdermal Drug Delivery Device Market Size by Country (2015-2020)
6.1.1 Europe Active Transdermal Drug Delivery Device Sales by Country (2015-2020)
6.1.2 Europe Active Transdermal Drug Delivery Device Revenue by Country (2015-2020)
6.2 Europe Active Transdermal Drug Delivery Device Market Size and Forecast by Country (2020-2025)
6.2.1 Europe Active Transdermal Drug Delivery Device Sales and Forecast by Country (2020-2025)
6.2.2 Europe Active Transdermal Drug Delivery Device Revenue and Forecast by Country (2020-2025)
6.3 Germany Active Transdermal Drug Delivery Device Market Size and Forecast (2015-2025)
6.4 United Kingdom Active Transdermal Drug Delivery Device Market Size and Forecast (2015-2025)
6.5 France Active Transdermal Drug Delivery Device Market Size and Forecast (2015-2025)
6.6 Russia Active Transdermal Drug Delivery Device Market Size and Forecast (2015-2025)
6.7 Italy Active Transdermal Drug Delivery Device Market Size and Forecast (2015-2025)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Active Transdermal Drug Delivery Device Market Size by Region (2015-2020)
7.1.1 Asia-Pacific Active Transdermal Drug Delivery Device Sales by Region (2015-2020)
7.1.2 Asia-Pacific Active Transdermal Drug Delivery Device Revenue by Region (2015-2020)
7.2 Asia-Pacific Active Transdermal Drug Delivery Device Market Size and Forecast by Region (2020-2025)
7.2.1 Asia-Pacific Active Transdermal Drug Delivery Device Sales and Forecast by Region (2020-2025)
7.2.2 Asia-Pacific Active Transdermal Drug Delivery Device Revenue and Forecast by Region (2020-2025)
7.3 China Active Transdermal Drug Delivery Device Market Size and Forecast (2015-2025)
7.4 Japan Active Transdermal Drug Delivery Device Market Size and Forecast (2015-2025)
7.5 Korea Active Transdermal Drug Delivery Device Market Size and Forecast (2015-2025)
7.6 India Active Transdermal Drug Delivery Device Market Size and Forecast (2015-2025)
7.7 Southeast Asia Active Transdermal Drug Delivery Device Market Size and Forecast (2015-2025)
7.8 Australia Active Transdermal Drug Delivery Device Market Size and Forecast (2015-2025)
8 South America by Country
8.1 South America Active Transdermal Drug Delivery Device Market Size by Country (2015-2020)
8.1.1 South America Active Transdermal Drug Delivery Device Sales by Country (2015-2020)
8.1.2 South America Active Transdermal Drug Delivery Device Revenue by Country (2015-2020)
8.2 South America Active Transdermal Drug Delivery Device Market Size and Forecast by Country (2020-2025)
8.2.1 South America Active Transdermal Drug Delivery Device Sales and Forecast by Country (2020-2025)
8.2.2 South America Active Transdermal Drug Delivery Device Revenue and Forecast by Country (2020-2025)
8.3 Brazil Active Transdermal Drug Delivery Device Market Size and Forecast (2015-2025)
8.4 Argentina Active Transdermal Drug Delivery Device Market Size and Forecast (2015-2025)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Active Transdermal Drug Delivery Device Market Size by Country (2015-2020)
9.1.1 Middle East & Africa Active Transdermal Drug Delivery Device Sales by Country (2015-2020)
9.1.2 Middle East & Africa Active Transdermal Drug Delivery Device Revenue by Country (2015-2020)
9.2 Middle East & Africa Active Transdermal Drug Delivery Device Market Size and Forecast by Country (2020-2025)
9.2.1 Middle East & Africa Active Transdermal Drug Delivery Device Sales and Forecast by Country (2020-2025)
9.2.2 Middle East & Africa Active Transdermal Drug Delivery Device Revenue and Forecast by Country (2020-2025)
9.3 Saudi Arabia Active Transdermal Drug Delivery Device Market Size and Forecast (2015-2025)
9.4 Turkey Active Transdermal Drug Delivery Device Market Size and Forecast (2015-2025)
9.5 Egypt Active Transdermal Drug Delivery Device Market Size and Forecast (2015-2025)
9.6 South Africa Active Transdermal Drug Delivery Device Market Size and Forecast (2015-2025)
10 Market Segment by Type
10.1 Global Active Transdermal Drug Delivery Device Market Size by Type (2015-2020)
10.1.1 Global Active Transdermal Drug Delivery Device Sales by Type (2015-2020)
10.1.2 Global Active Transdermal Drug Delivery Device Revenue by Type (2015-2020)
10.1.3 Global Active Transdermal Drug Delivery Device Price by Type (2015-2020)
10.2 Global Active Transdermal Drug Delivery Device Market Size and Forecast by Type (2020-2025)
10.2.1 Global Active Transdermal Drug Delivery Device Sales and Forecast by Type (2020-2025)
10.2.2 Global Active Transdermal Drug Delivery Device Revenue and Forecast by Type (2020-2025)
10.2.3 Global Active Transdermal Drug Delivery Device Price and Forecast by Type (2020-2025)
10.3 Japan Active Transdermal Drug Delivery Device Market Size and Forecast by Type (2015-2025)
10.3.1 Japan Active Transdermal Drug Delivery Device Market Size by Type (2015-2020)
10.3.2 Japan Active Transdermal Drug Delivery Device Market Size and Forecast by Type (2020-2025)
11 Market Segment by Application
11.1 Global Active Transdermal Drug Delivery Device Market Size by Application (2015-2020)
11.1.1 Global Active Transdermal Drug Delivery Device Sales by Application (2015-2020)
11.1.2 Global Active Transdermal Drug Delivery Device Revenue by Application (2015-2020)
11.1.3 Global Active Transdermal Drug Delivery Device Price by Application (2015-2020)
11.2 Global Active Transdermal Drug Delivery Device Market Size and Forecast by Application (2020-2025)
11.2.1 Global Active Transdermal Drug Delivery Device Sales and Forecast by Application (2020-2025)
11.2.2 Global Active Transdermal Drug Delivery Device Revenue and Forecast by Application (2020-2025)
11.2.3 Global Active Transdermal Drug Delivery Device Price and Forecast by Application (2020-2025)
11.3 Japan Active Transdermal Drug Delivery Device Market Size and Forecast by Application (2015-2025)
11.3.1 Japan Active Transdermal Drug Delivery Device Market Size by Application (2015-2020)
11.3.2 Japan Active Transdermal Drug Delivery Device Market Size and Forecast by Application (2020-2025)
12 Sales Channel, Distributors, Costumers, and Market Dynamics
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Distributors, Traders and Dealers
12.4.1 Market Opportunities
12.4.2 Market Risk
12.4.3 Market Driving Force
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
List of Tables
Table 1. Global Active Transdermal Drug Delivery Device Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Active Transdermal Drug Delivery Device by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Active Transdermal Drug Delivery Device Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Active Transdermal Drug Delivery Device Market Size Overview by Geography (2015-2020) (USD Million)
Table 5. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 6. Novartis AG Active Transdermal Drug Delivery Device Major Business
Table 7. Novartis AG Active Transdermal Drug Delivery Device Total Revenue (USD Million) (2018-2019)
Table 8. Novartis AG SWOT Analysis
Table 9. Novartis AG Active Transdermal Drug Delivery Device Product and Services
Table 10. Novartis AG Active Transdermal Drug Delivery Device Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 11. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 12. Bayer AG Active Transdermal Drug Delivery Device Major Business
Table 13. Bayer AG Active Transdermal Drug Delivery Device Total Revenue (USD Million) (2018-2019)
Table 14. Bayer AG SWOT Analysis
Table 15. Bayer AG Active Transdermal Drug Delivery Device Product and Services
Table 16. Bayer AG Active Transdermal Drug Delivery Device Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 17. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Basic Information, Manufacturing Base and Competitors
Table 18. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Major Business
Table 19. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Total Revenue (USD Million) (2018-2019)
Table 20. Johnson & Johnson (Janssen Pharmaceuticals Inc.) SWOT Analysis
Table 21. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Product and Services
Table 22. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 23. Noven Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Major Business
Table 25. Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Total Revenue (USD Million) (2018-2019)
Table 26. Noven Pharmaceuticals, Inc. SWOT Analysis
Table 27. Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Product and Services
Table 28. Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 29. Actavis, Inc. Basic Information, Manufacturing Base and Competitors
Table 30. Actavis, Inc. Active Transdermal Drug Delivery Device Major Business
Table 31. Actavis, Inc. Active Transdermal Drug Delivery Device Total Revenue (USD Million) (2018-2019)
Table 32. Actavis, Inc. SWOT Analysis
Table 33. Actavis, Inc. Active Transdermal Drug Delivery Device Product and Services
Table 34. Actavis, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 35. Transdermal Corp. Basic Information, Manufacturing Base and Competitors
Table 36. Transdermal Corp. Active Transdermal Drug Delivery Device Major Business
Table 37. Transdermal Corp. Active Transdermal Drug Delivery Device Total Revenue (USD Million) (2018-2019)
Table 38. Transdermal Corp. SWOT Analysis
Table 39. Transdermal Corp. Active Transdermal Drug Delivery Device Product and Services
Table 40. Transdermal Corp. Active Transdermal Drug Delivery Device Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 41. Corium International, Inc. Basic Information, Manufacturing Base and Competitors
Table 42. Corium International, Inc. Active Transdermal Drug Delivery Device Major Business
Table 43. Corium International, Inc. Active Transdermal Drug Delivery Device Total Revenue (USD Million) (2018-2019)
Table 44. Corium International, Inc. SWOT Analysis
Table 45. Corium International, Inc. Active Transdermal Drug Delivery Device Product and Services
Table 46. Corium International, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 47. 3M Basic Information, Manufacturing Base and Competitors
Table 48. 3M Active Transdermal Drug Delivery Device Major Business
Table 49. 3M Active Transdermal Drug Delivery Device Total Revenue (USD Million) (2018-2019)
Table 50. 3M SWOT Analysis
Table 51. 3M Active Transdermal Drug Delivery Device Product and Services
Table 52. 3M Active Transdermal Drug Delivery Device Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 53. Mylan N.V. Basic Information, Manufacturing Base and Competitors
Table 54. Mylan N.V. Active Transdermal Drug Delivery Device Major Business
Table 55. Mylan N.V. Active Transdermal Drug Delivery Device Total Revenue (USD Million) (2018-2019)
Table 56. Mylan N.V. SWOT Analysis
Table 57. Mylan N.V. Active Transdermal Drug Delivery Device Product and Services
Table 58. Mylan N.V. Active Transdermal Drug Delivery Device Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 59. Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors
Table 60. Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Major Business
Table 61. Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Total Revenue (USD Million) (2018-2019)
Table 62. Boehringer Ingelheim GmbH SWOT Analysis
Table 63. Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Product and Services
Table 64. Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 65. Echo Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 66. Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Major Business
Table 67. Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Total Revenue (USD Million) (2018-2019)
Table 68. Echo Therapeutics, Inc. SWOT Analysis
Table 69. Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Product and Services
Table 70. Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 71. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 72. GlaxoSmithKline plc Active Transdermal Drug Delivery Device Major Business
Table 73. GlaxoSmithKline plc Active Transdermal Drug Delivery Device Total Revenue (USD Million) (2018-2019)
Table 74. GlaxoSmithKline plc SWOT Analysis
Table 75. GlaxoSmithKline plc Active Transdermal Drug Delivery Device Product and Services
Table 76. GlaxoSmithKline plc Active Transdermal Drug Delivery Device Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 77. Global Active Transdermal Drug Delivery Device Sales by Manufacturer (2018-2019) (K Units)
Table 78. Global Active Transdermal Drug Delivery Device Revenue by Manufacturer (2018-2019) (USD Million)
Table 79. Key Players Active Transdermal Drug Delivery Device Sales in Japan (2018-2019) (K Units)
Table 80. Key Players Active Transdermal Drug Delivery Device Sales Market Share in Japan (2018-2019)
Table 81. Key Players Revenue of Active Transdermal Drug Delivery Device in Japan (2018-2019) (USD Million)
Table 82. Global Active Transdermal Drug Delivery Device Sales by Regions (2015-2020) (K Units)
Table 83. Global Active Transdermal Drug Delivery Device Sales Market Share by Regions (2015-2020)
Table 84. Global Active Transdermal Drug Delivery Device Revenue by Regions (2015-2020) (USD Million)
Table 85. Global Active Transdermal Drug Delivery Device Sales and Forecast by Regions (2020-2025) (K Units)
Table 86. Global Active Transdermal Drug Delivery Device Sales Market Share by Regions (2020-2025)
Table 87. Global Active Transdermal Drug Delivery Device Revenue and Forecast by Regions (2020-2025) (USD Million)
Table 88. Global Active Transdermal Drug Delivery Device Revenue Market Share by Regions (2020-2025) (USD Million)
Table 89. North America Active Transdermal Drug Delivery Device Sales by Countries (2015-2020) (K Units)
Table 90. North America Active Transdermal Drug Delivery Device Sales Market Share by Countries (2015-2020)
Table 91. North America Active Transdermal Drug Delivery Device Revenue by Countries (2015-2020) (USD Million)
Table 92. North America Active Transdermal Drug Delivery Device Revenue Market Share by Countries (2015-2020)
Table 93. North America Active Transdermal Drug Delivery Device Sales by Country (2020-2025) (K Units)
Table 94. North America Active Transdermal Drug Delivery Device Sales Market Share by Country (2020-2025)
Table 95. North America Active Transdermal Drug Delivery Device Revenue by Country (2020-2025) (USD Million)
Table 96. North America Active Transdermal Drug Delivery Device Revenue Market Share by Country (2020-2025)
Table 97. Europe Active Transdermal Drug Delivery Device Sales by Countries (2015-2020) (K Units)
Table 98. Europe Active Transdermal Drug Delivery Device Sales Market Share by Countries (2015-2020)
Table 99. Europe Active Transdermal Drug Delivery Device Revenue by Countries (2015-2020) (USD Million)
Table 100. Europe Active Transdermal Drug Delivery Device Revenue Market Share by Countries (2015-2020)
Table 101. Europe Active Transdermal Drug Delivery Device Sales by Country (2020-2025) (K Units)
Table 102. Europe Active Transdermal Drug Delivery Device Sales Market Share by Country (2020-2025)
Table 103. Europe Active Transdermal Drug Delivery Device Revenue by Country (2020-2025) (USD Million)
Table 104. Europe Active Transdermal Drug Delivery Device Revenue Market Share by Country (2020-2025)
Table 105. Asia-Pacific Active Transdermal Drug Delivery Device Sales by Countries (2015-2020) (K Units)
Table 106. Asia-Pacific Active Transdermal Drug Delivery Device Sales Market Share by Countries (2015-2020)
Table 107. Asia-Pacific Active Transdermal Drug Delivery Device Revenue by Countries (2015-2020) (USD Million)
Table 108. Asia-Pacific Active Transdermal Drug Delivery Device Revenue Market Share by Countries (2015-2020)
Table 109. Asia-Pacific Active Transdermal Drug Delivery Device Sales by Country (2020-2025) (K Units)
Table 110. Asia-Pacific Active Transdermal Drug Delivery Device Sales Market Share by Country (2020-2025)
Table 111. Asia-Pacific Active Transdermal Drug Delivery Device Revenue by Country (2020-2025) (USD Million)
Table 112. Asia-Pacific Active Transdermal Drug Delivery Device Revenue Market Share by Country (2020-2025)
Table 113. South America Active Transdermal Drug Delivery Device Sales by Countries (2015-2020) (K Units)
Table 114. South America Active Transdermal Drug Delivery Device Sales Market Share by Countries (2015-2020)
Table 115. South America Active Transdermal Drug Delivery Device Revenue by Countries (2015-2020) (USD Million)
Table 116. South America Active Transdermal Drug Delivery Device Revenue Market Share by Countries (2015-2020)
Table 117. South America Active Transdermal Drug Delivery Device Sales by Country (2020-2025) (K Units)
Table 118. South America Active Transdermal Drug Delivery Device Sales Market Share by Country (2020-2025)
Table 119. South America Active Transdermal Drug Delivery Device Revenue by Country (2020-2025) (USD Million)
Table 120. South America Active Transdermal Drug Delivery Device Revenue Market Share by Country (2020-2025)
Table 121. Middle East & Africa Active Transdermal Drug Delivery Device Sales by Countries (2015-2020) (K Units)
Table 122. Middle East & Africa Active Transdermal Drug Delivery Device Sales Market Share by Countries (2015-2020)
Table 123. Middle East & Africa Active Transdermal Drug Delivery Device Revenue by Countries (2015-2020) (USD Million)
Table 124. Middle East & Africa Active Transdermal Drug Delivery Device Revenue Market Share by Countries (2015-2020)
Table 125. Middle East & Africa Active Transdermal Drug Delivery Device Sales by Country (2020-2025) (K Units)
Table 126. Middle East & Africa Active Transdermal Drug Delivery Device Sales Market Share by Country (2020-2025)
Table 127. Middle East & Africa Active Transdermal Drug Delivery Device Revenue by Country (2020-2025) (USD Million)
Table 128. Middle East & Africa Active Transdermal Drug Delivery Device Revenue Market Share by Country (2020-2025)
Table 129. Japan Active Transdermal Drug Delivery Device Sales by Type (2015-2020) (K Units)
Table 130. Japan Active Transdermal Drug Delivery Device Sales Market Share by Type (2015-2020)
Table 131. Japan Active Transdermal Drug Delivery Device Revenue by Type (2015-2020) (USD Million)
Table 132. Japan Active Transdermal Drug Delivery Device Revenue Market Share by Type (2015-2020)
Table 133. Japan Active Transdermal Drug Delivery Device Sales by Type (2020-2025) (K Units)
Table 134. Japan Active Transdermal Drug Delivery Device Sales Market Share by Type (2020-2025)
Table 135. Japan Active Transdermal Drug Delivery Device Revenue by Type (2020-2025) (USD Million)
Table 136. Japan Active Transdermal Drug Delivery Device Revenue Market Share by Type (2020-2025)
Table 137. Global Active Transdermal Drug Delivery Device Sales by Application (2015-2020) (K Units)
Table 138. Global Active Transdermal Drug Delivery Device Sales Market Share by Application (2015-2020)
Table 139. Global Active Transdermal Drug Delivery Device Revenue by Application (2015-2020) (USD Million)
Table 140. Global Active Transdermal Drug Delivery Device Revenue Market Share by Application (2015-2020)
Table 141. Global Active Transdermal Drug Delivery Device Price by Application (2015-2020) (USD/Unit)
Table 142. Global Active Transdermal Drug Delivery Device Sales by Application (2020-2025) (K Units)
Table 143. Global Active Transdermal Drug Delivery Device Sales Market Share by Application (2020-2025)
Table 144. Global Active Transdermal Drug Delivery Device Revenue by Application (2020-2025) (USD Million)
Table 145. Global Active Transdermal Drug Delivery Device Revenue Market Share by Application (2020-2025)
Table 146. Global Active Transdermal Drug Delivery Device Price by Application (2020-2025) (USD/Unit)
Table 147. Japan Active Transdermal Drug Delivery Device Sales by Application (2015-2020) (K Units)
Table 148. Japan Active Transdermal Drug Delivery Device Sales Market Share by Application (2015-2020)
Table 149. Japan Active Transdermal Drug Delivery Device Revenue by Application (2015-2020) (USD Million)
Table 150. Japan Active Transdermal Drug Delivery Device Revenue Market Share by Application (2015-2020)
Table 151. Japan Active Transdermal Drug Delivery Device Sales by Application (2020-2025) (K Units)
Table 152. Japan Active Transdermal Drug Delivery Device Sales Market Share by Application (2020-2025)
Table 153. Japan Active Transdermal Drug Delivery Device Revenue by Application (2020-2025) (USD Million)
Table 154. Japan Active Transdermal Drug Delivery Device Revenue Market Share by Application (2020-2025)
Table 155. Direct Channel Pros & Cons
Table 156. Indirect Channel Pros & Cons
Table 157. Distributors/Traders/ Dealers List
Table 158. Customers of Active Transdermal Drug Delivery Device
Table 159. Market Opportunities in Next Few Years
Table 160. Market Risks Analysis
Table 161. Market Drivers
List of Figures
Figure 1. Active Transdermal Drug Delivery Device Picture
Figure 2. Global Active Transdermal Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. Patches Picture
Figure 4. Gels Picture
Figure 5. Active Transdermal Drug Delivery Device Sales Market Share by Application in 2019
Figure 6. Clinic Picture
Figure 7. Hospital Picture
Figure 8. Home Use Picture
Figure 9. Global Active Transdermal Drug Delivery Device Market Status and Outlook (2015-2025) (USD Million)
Figure 10. Global Active Transdermal Drug Delivery Device Sales Growth Rate (2015-2025) (K Units)
Figure 11. Global Active Transdermal Drug Delivery Device Sales Market Share by Manufacturer in 2019
Figure 12. Global Active Transdermal Drug Delivery Device Revenue Market Share by Manufacturer in 2019
Figure 13. Key Players Active Transdermal Drug Delivery Device Revenue Market Share in Japan in 2019
Figure 14. Global Top 5 Active Transdermal Drug Delivery Device Manufacturer Market Share in 2019
Figure 15. Top 3 Active Transdermal Drug Delivery Device Players Market Share in Japan in 2019
Figure 16. Global Active Transdermal Drug Delivery Device Revenue Market Share by Regions in 2019
Figure 17. North America Active Transdermal Drug Delivery Device Sales YoY Growth (2015-2025) (K Units)
Figure 18. North America Active Transdermal Drug Delivery Device Revenue YoY Growth (2015-2025) (USD Million)
Figure 19. Europe Active Transdermal Drug Delivery Device Sales YoY Growth (2015-2020) (K Units)
Figure 20. Europe Active Transdermal Drug Delivery Device Revenue YoY Growth (2015-2020) (USD Million)
Figure 21. Asia-Pacific Active Transdermal Drug Delivery Device Sales YoY Growth (2015-2020) (K Units)
Figure 22. Asia-Pacific Active Transdermal Drug Delivery Device Revenue YoY Growth (2015-2020) (USD Million)
Figure 23. South America Active Transdermal Drug Delivery Device Sales YoY Growth (2015-2020) (K Units)
Figure 24. South America Active Transdermal Drug Delivery Device Revenue YoY Growth (2015-2020) (USD Million)
Figure 25. Middle East & Africa Active Transdermal Drug Delivery Device Sales YoY Growth (2015-2020) (K Units)
Figure 26. Middle East & Africa Active Transdermal Drug Delivery Device Revenue YoY Growth (2015-2020) (USD Million)
Figure 27. North America Active Transdermal Drug Delivery Device Sales Market Share by Country in 2019
Figure 28. North America Active Transdermal Drug Delivery Device Revenue Market Share by Country in 2019
Figure 29. United States Active Transdermal Drug Delivery Device Market Size and Growth Rate (2015-2025) (USD Million)
Figure 30. Canada Active Transdermal Drug Delivery Device Market Size and Growth Rate (2015-2025) (USD Million)
Figure 31. Mexico Active Transdermal Drug Delivery Device Market Size and Growth Rate (2015-2020) (USD Million)
Figure 32. Europe Active Transdermal Drug Delivery Device Revenue Market Share by Country in 2019
Figure 33. Germany Active Transdermal Drug Delivery Device Market Size Growth Rate (2015-2025) (USD Million)
Figure 34. United Kingdom Active Transdermal Drug Delivery Device Market Size Growth Rate (2015-2025) (USD Million)
Figure 35. France Active Transdermal Drug Delivery Device Market Size Growth Rate (2015-2025) (USD Million)
Figure 36. Russia Active Transdermal Drug Delivery Device Market Size Growth Rate (2015-2025) (USD Million)
Figure 37. Italy Active Transdermal Drug Delivery Device Market Size Growth Rate (2015-2025) (USD Million)
Figure 38. Asia-Pacific Active Transdermal Drug Delivery Device Sales Market Share by Region 2018
Figure 39. Asia-Pacific Active Transdermal Drug Delivery Device Revenue Market Share by Region 2018
Figure 40. China Active Transdermal Drug Delivery Device Market Size Growth Rate (2015-2025) (USD Million)
Figure 41. Japan Active Transdermal Drug Delivery Device Market Size Growth Rate (2015-2025) (USD Million)
Figure 42. Korea Active Transdermal Drug Delivery Device Market Size Growth Rate (2015-2025) (USD Million)
Figure 43. India Active Transdermal Drug Delivery Device Market Size Growth Rate (2015-2025) (USD Million)
Figure 44. Southeast Asia Active Transdermal Drug Delivery Device Market Size Growth Rate (2015-2025) (USD Million)
Figure 45. Australia Active Transdermal Drug Delivery Device Market Size Growth Rate (2015-2025) (USD Million)
Figure 46. South America Active Transdermal Drug Delivery Device Sales Market Share by Country in 2019
Figure 47. South America Active Transdermal Drug Delivery Device Revenue Market Share by Country in 2019
Figure 48. Brazil Active Transdermal Drug Delivery Device Market Size Growth Rate (2015-2025) (USD Million)
Figure 49. Argentina Active Transdermal Drug Delivery Device Market Size Growth Rate (2015-2025) (USD Million)
Figure 50. Saudi Arabia Active Transdermal Drug Delivery Device Market Size Growth Rate (2015-2025) (USD Million)
Figure 51. Turkey Active Transdermal Drug Delivery Device Market Size Growth Rate (2015-2025) (USD Million)
Figure 52. Egypt Active Transdermal Drug Delivery Device Market Size Growth Rate (2015-2025) (USD Million)
Figure 53. South Africa Active Transdermal Drug Delivery Device Market Size Growth Rate (2015-2025) (USD Million)
Figure 54. Global Revenue Market Share of Active Transdermal Drug Delivery Device by Type in 2019
Figure 55. Global Revenue Market Share of Active Transdermal Drug Delivery Device by Application in 2019
Figure 56. Sales Channel: Direct Channel vs Indirect Channel
Please feel free to write an email to us or to use our electronic ticketing system.
